drugset / Trial / NCT07867171
A Study to Investigate the Effects of Moderate or Severe Renal Impairment (RI) on Velzatinib
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates the effect of moderate and severe renal impairment on the pharmacokinetics (PK) of velzatinib compared with normal renal function.
Timeline
- Start
- 2026-10-23
- Primary completion
- 2027-09-09
- Completion
- 2027-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IDRX-42 | Small molecule | — | — |